Why it was recalled
Microbial Contamination of Non-Sterile Products: The products have been found to contain yeast/mold and microbial contamination identified as Achromobacter.
Product description
ReBoost Nasal Spray, 0.68 fl. oz. (20 mL) bottles, Distributed by: MediNatura, 10421 Research Rd., SE, Albuquerque, NM 87123, NDC 62795-4005-9, UPC 787647101863
Lot numbers, UPCs & expiration codes
All lots within expiry.
Where it was sold
Nationwide in the US
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0288-2026
- Classification
- Class I
- Status
- Ongoing
- Recall initiated
- Dec 12, 2025
- FDA report date
- Jan 14, 2026
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Medinatura New Mexico, inc.
Original FDA data
Every field from FDA enforcement report D-0288-2026, exactly as published.
Show all FDA fields
- City
- Albuquerque
- State
- NM
- Status
- Ongoing
- Country
- United States
- Event ID
- 98095
- Address
- 10421 Research Rd Se
- Code information
- All lots within expiry.
- Postal code
- 87123-3423
- Report date
- Jan 14, 2026
- Product type
- Drugs
- Recall number
- D-0288-2026
- Classification
- Class I
- Recalling firm
- Medinatura New Mexico, inc.
- Reason for recall
- Microbial Contamination of Non-Sterile Products: The products have been found to contain yeast/mold and microbial contamination identified as Achromobacter.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- ReBoost Nasal Spray, 0.68 fl. oz. (20 mL) bottles, Distributed by: MediNatura, 10421 Research Rd., SE, Albuquerque, NM 87123, NDC 62795-4005-9, UPC 787647101863
- Distribution pattern
- Nationwide in the US
- Recall initiation date
- Dec 12, 2025
- Initial firm notification
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
- Center classification date
- Jan 15, 2026